COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
October 2013

26

October
2013

category:

503b Compounding

Novo Nordisk recalls diabetes drugs in Europe

Novo Nordisk is recalling 3 million insulin products used for diabetes treatment in 13 European countries due to a production problem that can affect the strength of the drug. The Danish drug maker says Friday’s recall affects certain batches of the prefilled insulin pen NovoMix30 FlexPen in Austria, Belgium, Czech Republic, Denmark, France, Germany, Iceland, […]

read more

26

October
2013

category:

503b Compounding

Repost: Cancer drug shortages create greater risk, costs

Cancer drug shortages are forcing treatment changes and delays that for some patients have led to worse outcomes, more therapy-related complications and higher costs, according to a national survey of health professionals published Thursday. According to the survey results, of the 243 individuals who completed the survey, 98 percent reported having dealt with a shortage […]

read more

26

October
2013

category:

503b Compounding

Tackling America’s greatest drug problem

America has a major drug problem, but it’s not the one that probably comes immediately to mind. It is a continual and rotating shortage of important drugs needed to treat a variety of legitimate medical conditions impacting patients and the healthcare supply chain. The drug shortage issue has been an ongoing problem in recent years, […]

read more